Related Experiment Video
Updated: Jun 7, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
The Impact of Comorbidity and Age on the Risk of Hospitalization and Mortality in Patients with Previous COVID-19
Ken Lund1,2, Jan Nielsen1,2, Simon Kjeldsen3
1Center for Clinical Epidemiology, Odense University Hospital, 5000 Odense, Denmark.
Insights
Comorbidity significantly increases hospitalization and mortality risk for adults and older adults up to two years after COVID-19. Specific underlying conditions, like dementia, further elevate mortality risks, especially in older populations.
Area of Science:
- Infectious Diseases
- Epidemiology
- Gerontology
Background:
- Long-term outcomes of COVID-19, particularly concerning comorbidity, remain underexplored in adults and older adults.
- Understanding the impact of pre-existing conditions on post-COVID-19 hospitalization and mortality is crucial for public health.
- The Charlson Comorbidity Index (CCI) is a widely used measure for quantifying disease burden.
Purpose of the Study:
- To investigate the influence of comorbidity on long-term hospitalization and mortality following COVID-19 infection.
- To compare risks between adults (40-59 years) and older adults (≥60 years) based on comorbidity levels.
- To identify specific underlying diseases that contribute most significantly to adverse outcomes after COVID-19.
Main Methods:
- A Danish population-based cohort study included over 1 million individuals with a positive COVID-19 PCR test.
- Patients were categorized by Charlson Comorbidity Index (CCI) scores (0, 1-2, ≥3) and age groups (adults, older adults).
- Cox regression models were used to estimate adjusted hazard ratios (HR) for hospitalization and mortality, controlling for confounders.
Main Results:
- A CCI score of ≥3 was associated with significantly higher adjusted HRs for hospitalization (4.54 in adults, 3.05 in older adults) and mortality (21.04 in adults, 4.61 in older adults).
- Individual disease categories within the CCI influenced risk estimates, with dementia showing the most substantial impact on mortality.
- Increased risk of hospitalization and mortality was observed even with a CCI score of 1 or above.
Conclusions:
- Comorbidity, as indicated by a CCI score of 1 or higher, substantially increases the risk of hospitalization and mortality for up to two years post-COVID-19.
- The specific type of underlying disease significantly modifies the risk of adverse outcomes, particularly in older adults.
- These findings highlight the importance of managing comorbidities in individuals diagnosed with COVID-19 to mitigate long-term health consequences.
Abstract:
Objectives: The influence of comorbidity on long-term hospitalization and mortality after COVID-19 in adults (40-59 years) and older adults (≥60 years) is yet to be explored. Methods: This is a Danish population-based cohort study of patients with a first-time positive PCR test for COVID-19 from 1 March 2020, to 28 February 2022 (N = 1,034,103). Exposed cohorts were patients with 1) a Charlson Comorbidity Index (CCI) score of 1-2 and 2) a CCI score ≥3, who were compared to patients without comorbidity (CCI of zero) within the groups of adults (67.9%) and older adults (32.1%) for the risk of hospitalization and mortality. Next, within the age groups, each disease category of the CCI was considered as an exposed cohort and compared to patients who did not have the specific disease of interest. Adjusted hazard ratios (HR) for hospitalization and mortality were estimated by Cox regression models adjusted for confounders. Results: The highest HRs were in adult patients with a CCI score of ≥3. The adjusted HR was 4.54 (95%CI: 4.38-4.70) for hospitalization, and among older adults it was 3.05 (95%CI: 2.99-3.11). The adjusted HR for mortality among adults with a CCI score ≥3 was 21.04 (95%CI: 18.86-23.47), and the adjusted HR for mortality among older adults was 4.61 (95%CI: 4.44-4.78). The underlying disease influenced the risk estimates among adults and older adults, and "dementia" had the highest impact on mortality. Conclusion: A CCI score of 1 or above increases the risk of hospitalization and mortality up to 2 years after a positive PCR test of COVID-19 for adults and older adults. Further, the type of underlying disease in older adults highly influences the risk of hospitalization and mortality.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pneumonia III: Complications and Assessment
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Comparing the Survival Analysis of Two or More Groups
Causality in Epidemiology
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

